Skip to main content
Top
Published in: International Journal of Colorectal Disease 9/2007

01-09-2007 | Original Article

The prevalence of ocular involvement in patients with inflammatory bowel disease

Authors: Safiye Yilmaz, Ebru Aydemir, Ahmet Maden, Belkis Unsal

Published in: International Journal of Colorectal Disease | Issue 9/2007

Login to get access

Abstract

Purpose

The aim of this prospective randomized clinical study was to evaluate the prevalence of ocular involvement in patients with inflammatory bowel disease (IBD).

Materials and methods

We prospectively evaluated 116 patients who went to the gastroenterology clinic with endoscopically proven IBD between December 2001 and February 2005. All patients were examined for evidence of ocular manifestations of IBD. Twenty patients had Crohn’s disease and 96 had ulcerative colitis. The examination consisted of slit-lamp examinations, tonometry, visual acuity, and indirect ophthalmoscopy.

Results

The mean age of the 116 patients with IBD who were enrolled was 40.6 ± 14.4 years (range 16 to 75). Twelve of 20 patients (60%) with Crohn’s disease and 22 of 96 patients (22.92%) with ulcerative colitis had ocular involvement. The most common ocular findings were conjunctivitis (8.62%) and blepharitis (6.9%) followed by uveitis (5.17%), cataract (5.17%), and episcleritis (3.45%). Extraintestinal complications were seen in 12 (35.3%) of 34 patients with ocular involvement and in 16 (19.5%) of 82 patients without ocular involvement.

Conclusion

Because the ocular complaints of IBD patients are often nonspecific, it may be helpful to performed eye examinations as a routine component in the follow-up of these patients. It is well-known that early diagnosis and treatment of ocular involvement may prevent serious ocular complications that could be associated with significant visual morbidity. In addition, clinicians should be aware that some ocular diseases, such as uveitis and scleritis, might precede a diagnosis of ulcerative colitis or Crohn’s disease.
Literature
1.
go back to reference Knox DL, Schachat AP, Mustonen E (1984) Primary, secondary and coincidental ocular complications of Crohn’s disease. Ophthalmology 91:163–173PubMed Knox DL, Schachat AP, Mustonen E (1984) Primary, secondary and coincidental ocular complications of Crohn’s disease. Ophthalmology 91:163–173PubMed
2.
go back to reference Faruque D, Ghanchi MS, Rembacken BJ (2003) Inflammatory bowel disease and the eye. Surv Ophthalmol 48(6):663–676CrossRef Faruque D, Ghanchi MS, Rembacken BJ (2003) Inflammatory bowel disease and the eye. Surv Ophthalmol 48(6):663–676CrossRef
3.
go back to reference Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis. A study of 700 patients. Medicine 55:401–412PubMed Greenstein AJ, Janowitz HD, Sachar DB (1976) The extra-intestinal complications of Crohn’s disease and ulcerative colitis. A study of 700 patients. Medicine 55:401–412PubMed
4.
go back to reference Hopkins DJ, Horan E, Burton IL et al (1974) Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol 58:732PubMedCrossRef Hopkins DJ, Horan E, Burton IL et al (1974) Ocular disorders in a series of 332 patients with Crohn’s disease. Br J Ophthalmol 58:732PubMedCrossRef
5.
go back to reference Rachmilewitz D (on behalf of an international study group) (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82–86CrossRef Rachmilewitz D (on behalf of an international study group) (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomized trial. Br Med J 298:82–86CrossRef
6.
go back to reference Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444PubMed Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444PubMed
7.
go back to reference Crohn BB (1925) Ocular lesions complicating ulcerative colitis. Am J Med Sci 169:260–267 Crohn BB (1925) Ocular lesions complicating ulcerative colitis. Am J Med Sci 169:260–267
8.
go back to reference Cohen RD, Hanauer SB (1995) Immunomodulatory agents and other medical therapies in inflammatory bowel disease. Curr Opin Gastroenterol 11:321–330CrossRef Cohen RD, Hanauer SB (1995) Immunomodulatory agents and other medical therapies in inflammatory bowel disease. Curr Opin Gastroenterol 11:321–330CrossRef
9.
go back to reference Petrelli EA, McKinley M, Troncale FJ (1982) Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 14(4):356–360PubMed Petrelli EA, McKinley M, Troncale FJ (1982) Ocular manifestations of inflammatory bowel disease. Ann Ophthalmol 14(4):356–360PubMed
10.
go back to reference Ernst BB, Lowder CY, Meisler DM, Gutman FA (1991) Posterior segment manifestations of inflammatory bowel disease. Ophthalmology 98:1272–1280PubMed Ernst BB, Lowder CY, Meisler DM, Gutman FA (1991) Posterior segment manifestations of inflammatory bowel disease. Ophthalmology 98:1272–1280PubMed
11.
go back to reference Schulman MF, Sugar A (1981) Peripheral corneal infiltrates in inflammatory bowel disease. Ann Ophthalmol 13:109–111PubMed Schulman MF, Sugar A (1981) Peripheral corneal infiltrates in inflammatory bowel disease. Ann Ophthalmol 13:109–111PubMed
12.
go back to reference Knox DL, Snip RC, Stark WJ (1980) The keratopathy of Crohn’s disease. Am J Ophthalmol 90:862–865PubMed Knox DL, Snip RC, Stark WJ (1980) The keratopathy of Crohn’s disease. Am J Ophthalmol 90:862–865PubMed
13.
go back to reference Lyons JL, Rosenbaum JT (1997) Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 115:61–64PubMed Lyons JL, Rosenbaum JT (1997) Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 115:61–64PubMed
14.
go back to reference Soukiasian SH, Stephen Foster C, Raizman MB (1994) Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol 118:601–611PubMed Soukiasian SH, Stephen Foster C, Raizman MB (1994) Treatment strategies for scleritis and uveitis associated with inflammatory bowel disease. Am J Ophthalmol 118:601–611PubMed
15.
go back to reference Rankin GB, Watts HD, Melnyk CS, Kelly ML Jr (1979) National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology 77:914–920PubMed Rankin GB, Watts HD, Melnyk CS, Kelly ML Jr (1979) National cooperative Crohn’s disease study: extraintestinal manifestations and perianal complications. Gastroenterology 77:914–920PubMed
16.
go back to reference Salmon JF, Wright JP, Murray AND (1997) Ocular inflammation in Crohn’s disease. Ophthalmology 98:480–484 Salmon JF, Wright JP, Murray AND (1997) Ocular inflammation in Crohn’s disease. Ophthalmology 98:480–484
Metadata
Title
The prevalence of ocular involvement in patients with inflammatory bowel disease
Authors
Safiye Yilmaz
Ebru Aydemir
Ahmet Maden
Belkis Unsal
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
International Journal of Colorectal Disease / Issue 9/2007
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-007-0275-1

Other articles of this Issue 9/2007

International Journal of Colorectal Disease 9/2007 Go to the issue